Natasha Giordano

CIK 1315585 · Chief Executive Officer · last filed 2025-12-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$168.8K

Companies

5

Total Filings

25

Lifetime Open-Market Net

-$62.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OGEN Director $0.62 $0 1 2025-12-15
MTNB Director $0.78 $0 3 2023-11-03
PLx Pharma Inc. (PLXP) Delisted Chief Executive Officer 5,186 $0.09 $451 $15.0K 8 2022-03-16
ACET Director 20,972 $8.05 $168.8K -$77.2K 9 2017-12-11
DENDRITE INTERNATIONAL INC (DRTE) Delisted Pres., Global Business Unit 75,204 $0 2 2007-05-03

Recent Filings · Page 3 of 3

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-12-10 ACET Grant (A) +4,954 $48.0K EDGAR
2011-12-16 ACET Grant (A) +6,934 $45.0K EDGAR
2007-05-11 Disp (D) −75,204 -$1.20M
2007-05-03 DENDRITE INTERNATIONAL INC (DRTE) Delisted Tax (F) −4,005 -$63.8K EDGAR
2007-01-29 DENDRITE INTERNATIONAL INC (DRTE) Delisted Grant (A) +33,000 $0 EDGAR
Showing 2125 of 25
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.